NR

Nallapet Ramaswamy Ramesh Babu

Active Director Designated Partner DIN 09491842
DIN 09491842 First appointment Feb 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Nallapet Ramaswamy Ramesh Babu

Data last updated:

Nallapet Ramaswamy Ramesh Babu is a Designated Partner at Pillzy Health Care Llp (since 2022). The company operates in Pharma.

DIN 09491842
Primary Designation Designated Partner
Industry Pharma
First Appointment 03 Feb 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner03 Feb 20222022Active

Board colleagues of Nallapet Ramaswamy Ramesh Babu

NameDINCompanyDesignation
Arjun Ramesh Babu Nallapeta09491841Pillzy Health Care LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Pillzy Health Care Llp
Premium access

Shareholding and investment profile for Nallapet Ramaswamy Ramesh Babu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nallapet Ramaswamy Ramesh Babu

Nallapet Ramaswamy Ramesh Babu currently holds 1 directorship: Pillzy Health Care Llp (Designated Partner, since 03 Feb 2022).

Nallapet Ramaswamy Ramesh Babu was first appointed on 03 Feb 2022 as Designated Partner at Pillzy Health Care Llp.

The current boards of Nallapet Ramaswamy Ramesh Babu's companies include Arjun Ramesh Babu Nallapeta (Pillzy Health Care Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available